Elevance Health, Inc. (ELV)
- Previous Close
538.77 - Open
539.67 - Bid 523.10 x 800
- Ask 534.95 x 800
- Day's Range
533.54 - 540.22 - 52 Week Range
412.00 - 543.13 - Volume
468,446 - Avg. Volume
971,050 - Market Cap (intraday)
124.258B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
20.17 - EPS (TTM)
26.51 - Earnings Date Jul 17, 2024 - Jul 22, 2024
- Forward Dividend & Yield 6.52 (1.21%)
- Ex-Dividend Date Jun 10, 2024
- 1y Target Est
605.45
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
www.elevancehealth.com104,900
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ELV
Performance Overview: ELV
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELV
Valuation Measures
Market Cap
125.22B
Enterprise Value
145.44B
Trailing P/E
20.32
Forward P/E
14.47
PEG Ratio (5yr expected)
0.90
Price/Sales (ttm)
0.74
Price/Book (mrq)
3.08
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
3.64%
Return on Assets (ttm)
5.78%
Return on Equity (ttm)
15.95%
Revenue (ttm)
171.75B
Net Income Avi to Common (ttm)
6.24B
Diluted EPS (ttm)
26.51
Balance Sheet and Cash Flow
Total Cash (mrq)
36.27B
Total Debt/Equity (mrq)
64.97%
Levered Free Cash Flow (ttm)
-261.12M
Research Analysis: ELV
Company Insights: ELV
ELV does not have Company Insights